Commonly Prescribed First-Generation Antipsychotics Examples of commonly prescribed first-generation antipsychotics include the following: Adasuve (loxapine) is FDA-approved to treat the following: ...

The paper 1, "The experiences of 585 people when they tried to withdraw from antipsychotic drugs," reports on an online survey completed by people from 29 countries who had taken, or were still ...

CONVENTIONAL ANTIPSYCHOTIC DRUGS, used for a half century to treat a range of major psychiatric disorders, are being replaced in clinical practice by modern “atypical” antipsychotics, including ...

Percentage of children prescribed antipsychotics, per year 2000 to 2019. Although antipsychotics are most commonly being prescribed for children with autism and psychosis, they are also being ...

BACKGROUND: Trazodone is increasingly prescribed for behavioural and psychological symptoms of dementia, but little is known about its risk of harm. Our objective was to describe the comparative risk ...

Winnipeg nursing home residents are being prescribed powerful antipsychotic drugs at an increasing rate to treat dementia and control behaviour, rather than what the drugs are meant for — to ...

It is possible that doctors prescribed the older antipsychotic haloperidol more often than newer medications in patients who were more likely to die, or that patients using the antipsychotic drugs ...

With the increase in the number of people aged 65 years or older comes an expected increase in demand for nursing homes. The market size for long-term care is USD 1.2 trillion in 2024 and is ...

Antipsychotics are often prescribed in nursing homes "off-label," meaning they're used for purposes not approved by health authorities like the U.S. Food and Drug Administration (FDA).

Warning letters to primary care physicians (PCPs) regarding overprescription of quetiapine were helpful in reducing overprescribing of this agent, new research suggested. Investigators analyzed ...

The use of antipsychotics for schizophrenia was associated with higher risk for severe cases of COVID-19 and non–COVID-19 respiratory infections but not mild infection.